Tag Archives: Human papillomavirus

Two doses of HPV vaccine as good as three, study shows

According to data from the National Cancer Institute’s Costa Rica Vaccine Trial, two does of the human papillomavirus vaccine may offer as much protection against cervical cancer as the three dose regimen currently being used. Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

Study shows HPV vaccine can be delayed with minimal loss of effectiveness

A recent study conducted by Kathleen M. Neuzil has found that delaying doses of the vaccine against human papilloma virus until months later than recommended does not make the vaccine less safe or effective. Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

Only one-third of U.S. women receive full HPV vaccine

A recent study showed that only around one-third of eligible young U.S. women complete the full course of the human papillomavirus vaccine. Read More »

Filed in Medical Countermeasures, News | Tagged | Comments Off

Experts debate HPV vaccine for males

Federal vaccine advisors began deciding on October 28 whether or not two vaccines that protect against sexually transmitted diseases that can cause genital warts and cancers should be used widely in boys and young men. Read More »

Filed in News, Vaccine Development | Tagged | Comments Off

Grant awarded for trial of new HPV vaccine

Researchers with the University of Arkansas for Medical Sciences have been awarded a $3.3 million grant for clinical trials of a new HPV vaccine. Read More »

Filed in News | Tagged | Comments Off

Cervarix license amended for additional HPV strains

GlaxoSmithKline Read More »

Filed in News | Tagged | Comments Off

HPV vaccine may protect against genital warts

The results of a four-year study released on July 20 by the British Medical Journal show that vaccination against certain types of human papillomavirus gives protection against genital warts and pre-cancerous growths of the cervix. Read More »

Filed in News, Vaccine Development | Tagged | Comments Off

QIAGEN HPV test improves cervical cancer control

Researchers with QIAGEN said a recent study has shown that Latin American women who used its human papillomavirus test showed improved cervical cancer control when compared to regular cytology testing. Read More »

Filed in News, Vaccine Development | Tagged | Comments Off

Dynavax awarded grant for universal HPV vaccine

Experts converge on Montreal for HPV conference

FDA extends review of Gardasil for older recipients

Only a third of women being vaccinated for HPV

Older women not likely to benefit from cervical cancer vaccine

Inovio Biomedical vaccine for cervical cancer generates response

Cervarix vaccine approved in Canada

Cervical cancer vaccine will cut cases by two thirds, experts calculate

Experimental vaccine cures pre-cancer vulvar growths

Vaccinating boys against human papillomavirus not cost-effective